Search Results - "O’Brien, Bernie"

Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions by Fenwick, Elisabeth, O'Brien, Bernie J., Briggs, Andrew

“…Cost‐effectiveness acceptability curves (CEACs) have been widely adopted as a method to quantify and graphically represent uncertainty in economic evaluation…”
Get full text

Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies by Weinstein, Milton C., O'Brien, Bernie, Hornberger, John, Jackson, Joseph, Johannesson, Magnus, McCabe, Chris, Luce, Bryan R.

“…Mathematical modeling is used widely in economic evaluations of pharmaceuticals and other health-care technologies. Users of models in government and the…”
Get full text

Quality of life in the Canadian Implantable Defibrillator Study (CIDS) by Irvine, Jane, Dorian, Paul, Baker, Brian, O'Brien, Bernie J., Roberts, Robin, Gent, Michael, Newman, David, Connolly, Stuart J.

“…Background The primary aim of this study was to compare quality-of-life outcome between patients randomized to implantable cardioverter defibrillator (ICD)…”
Get full text

Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies by Briggs, Andrew H, O'Brien, Bernie J, Blackhouse, Gordon

“…As many more clinical trials collect economic information within their study design, so health economics analysts are increasingly working with patient-level…”
Get full text

Cost-effectiveness of Rhythm versus Rate control in Atrial fibrillation by MARSHALL, Deborah A, LEVY, Adrian R, VIDAILLET, Humberto, FENWICK, Elisabeth, SLEE, April, BLACKHOUSE, Gordon, GREENE, H. Leon, WYSE, D. George, NICHOL, Graham, OBRIEN, Bernie J

“…Atrial fibrillation is the most common type of sustained cardiac arrhythmia, but recent trials have identified no clear advantage of rhythm control over rate…”
Get full text

The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty by Skedgel, Chris, Goeree, Ron, Pleasance, Sue, Thompson, Kara, OʼBrien, Bernie, Anderson, David

“…BackgroundAlthough the risk of thromboembolism after total hip arthroplasty continues beyond hospital discharge, the cost-effectiveness of extending…”
Get full text

Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease by Briggs, Andrew H, Goeree, Ron, Blackhouse, Gord, O'Brien, Bernie J

“…When choosing between mutually exclusive treatment options, it is common to construct a cost-effectiveness frontier on the cost-effectiveness plane that…”
Get full text

Systematic Implementation of an Advance Directive Program in Nursing Homes: A Randomized Controlled Trial by Molloy, D. William, Guyatt, Gordon H, Russo, Rosalie, Goeree, Ron, O'Brien, Bernie J, Bédard, Michel, Willan, Andy, Watson, Jan, Patterson, Christine, Harrison, Christine, Standish, Tim, Strang, David, Darzins, Peteris J, Smith, Stephanie, Dubois, Sacha

“…CONTEXT Although advance directives are commonly used in the community, little is known about the effects of their systematic implementation. OBJECTIVES To…”
Get full text

Age, Health and the Willingness to Pay for Mortality Risk Reductions: A Contingent Valuation Survey of Ontario Residents by KRUPNICK, ALAN, ALBERINI, ANNA, CROPPER, MAUREEN, SIMON, NATHALIE, O'BRIEN, BERNIE, GOEREE, RON, HEINTZELMAN, MARTIN

“…We present the results of a contingent valuation survey eliciting willingness to pay (WTP) for mortality risk reductions. The survey was self-administered…”
Get full text

Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis by Lynd, Larry D., O'Brien, Bernie J.

“…To demonstrate the use of probabilistic simulation modeling to estimate the joint density of therapeutic risks and benefits. Published data are used to…”
Get full text

Cost-effectiveness of the Implantable cardioverter-defibrillator : Results from the Canadian Implantable Defibrillator Study (CIDS) by O'BRIEN, Bernie J, CONNOLLY, Stuart J, GOEREE, Ron, BLACKHOUSE, Gordon, WILLAN, Andrew, YEE, Raymond, ROBERTS, Robin S, GENT, Michael

“…In the Canadian Implantable Defibrillator Study (CIDS), we assessed the cost-effectiveness of the implantable cardioverter-defibrillator (ICD) in reducing the…”
Get full text

Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budget by Zaric, Gregory S., O'Brien, Bernie J.

“…Many public and private healthcare payers use formularies as a tool for controlling drug costs and quality. Although the price per dose is often negotiated as…”
Get full text

Is there a kink in consumers' threshold value for cost-effectiveness in health care? by O'Brien, Bernie J., Gertsen, Kirsten, Willan, Andrew R., Faulkner, A.

“…Background: A reproducible observation is that consumers' willingness‐to‐accept (WTA) monetary compensation to forgo a program is greater than their stated…”
Get full text

Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria by Coyle, Douglas, Buxton, Martin J., O'Brien, Bernie J.

“…The cost‐effectiveness of new health care technologies is conditional upon who receives what therapy and under what circumstances. Understanding this…”
Get full text

Cost-effectiveness analysis for multinational clinical trials by Pinto, Eleanor M., Willan, Andrew R., O'Brien, Bernie J.

“…Clinical trials of cost–effectiveness are often conducted in more than one country. The two most common ways of dealing with the multinational nature of the…”
Get full text

Effect of clinical risk stratification on cost-effectiveness of the Implantable cardioverter-defibrillator: The Canadian Implantable Defibrillator Study by SHELDON, Robert, O'BRIEN, Bernie J, BLACKHOUSE, Gordon, GOEREE, Ron, MITCHELL, Brent, KLEIN, George, ROBERTS, Robin S, GENT, Michael, CONNOLLY, Stuart J

“…Three randomized clinical trials showed that implantable cardioverter-defibrillators (ICDs) reduce the risk of death in survivors of ventricular…”
Get full text

Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus by Reed, Shelby D., Anstrom, Kevin J., Bakhai, Ameet, Briggs, Andrew H., Califf, Robert M., Cohen, David J., Drummond, Michael F., Glick, Henry A., Gnanasakthy, Ari, Hlatky, Mark A., O'Brien, Bernie J., Torti, Frank M., Tsiatis, Anastasios A., Willan, Andrew R., Mark, Daniel B., Schulman, Kevin A.

“…Demand for economic evaluations in multinational clinical trials is increasing, but there is little consensus about how such studies should be conducted and…”
Get full text

Antiviral agents for influenza : A comparison of cost-effectiveness data by LYND, Larry D, GOEREE, Ron, O'BRIEN, Bernie J

“…The economic burden of influenza-related illness has been estimated to be 71.3-166 billion US dollars in the US, the majority of which is attributable to…”
Get full text

The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty by SKEDGEL, Chris, GOEREE, Ron, PLEASANCE, Sue, THOMPSON, Kara, O'BRIEN, Bernie, ANDERSON, David

“…Although the risk of thromboembolism after total hip arthroplasty continues beyond hospital discharge, the cost-effectiveness of extending prophylaxis beyond…”
Get full text

Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem by Willan, Andrew R., O'Brien, Bernie J.

“…Application of cost‐effectiveness analysis (CEA) is growing rapidly in health care. Two general approaches to analysis are differentiated by the type of data…”
Get full text